PDLI Operating Income Growth
Pdl Biopharma Inc · Operating Income Growth
PDLI Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-689.67%period ending
PDLI TTM Operating Income YoY % (2.96% → -689.67%)
Year-over-year change
High-resolution chart · PNG
PDLI operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -689.6743% | |
| -361.8388% | |
| -222.6859% | |
| -200.8913% | |
| -110.8876% | |
| -68.2281% | |
| -55.4138% | |
| -62.6% | |
| -62.5922% | |
| -67.3346% | |
| 96.629% | |
| 14.7921% | |
| -32.4591% | |
| -47.8702% | |
| -82.1999% | |
| -70.3456% | |
| -38.2387% | |
| -26.6033% | |
| -7.0428% | |
| 3.9866% | |
| -12.2844% | |
| 7.2267% | |
| 13.5929% | |
| 22.2713% | |
| 30.7424% | |
| 19.2442% | |
| 22.7627% | |
| 16.3986% | |
| 14.3449% | |
| 11.2205% | |
| 7.1024% | |
| 1.239% | |
| 36.7879% | |
| 39.8976% | |
| 43.441% | |
| 63.8391% | |
| -14.8512% | |
| -13.8673% | |
| -18.9661% | |
| -28.9583% | |
| -23.706% | |
| -14.4549% | |
| 10.0045% | |
| 22.4096% | |
| 336.6304% | |
| 367.8259% | |
| 749.2861% | |
| 1,751.422% | |
| 198.4645% | |
| 177.3615% | |
| 127.7444% | |
| 88.5565% | |
| -50.528% | |
| -0.52% | |
| -28.7104% | |
| -93.7343% | |
| 2.6337% | |
| -133.4326% | |
| -74.5177% | |
| -13.6293% | |
| -0.4611% | |
| 40.2139% | |
| 14.9169% | |
| -32.1248% | |
| -66.1879% | |
| -124.4997% | |
| -123.1976% | |
| -87.44% | |
| -124.0064% | |
| -784.3436% | |
| -483.704% | |
| -302.4491% | |
| -361.9923% | |
| -64.2321% | |
| 250.1309% | |
| 180.0454% | |
| 144.3111% | |
| 75.5324% | |
| 71.3213% | |
| 23.8848% | |
| 25.1283% | |
| 55.3552% | |
| 4.3293% | |
| -1.0582% | |
| -4.4693% | |
| 7.1066% | |
| 23.0415% | |
| 10% | |
| -1.1299% | |
| 2.9557% |